BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 31993419)

  • 1. Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate.
    Arnold PR; Wells AD; Li XC
    Front Cell Dev Biol; 2019; 7():377. PubMed ID: 31993419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription.
    Mikhaylichenko O; Bondarenko V; Harnett D; Schor IE; Males M; Viales RR; Furlong EEM
    Genes Dev; 2018 Jan; 32(1):42-57. PubMed ID: 29378788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancer RNA: What we know and what we can achieve.
    Han Z; Li W
    Cell Prolif; 2022 Apr; 55(4):e13202. PubMed ID: 35170113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer RNAs step forward: new insights into enhancer function.
    Harrison LJ; Bose D
    Development; 2022 Aug; 149(16):. PubMed ID: 36039999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions.
    Wu M; Shen J
    Front Oncol; 2019; 9():1307. PubMed ID: 31824865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene.
    Pnueli L; Rudnizky S; Yosefzon Y; Melamed P
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4369-74. PubMed ID: 25810254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
    Jiao W; Chen Y; Song H; Li D; Mei H; Yang F; Fang E; Wang X; Huang K; Zheng L; Tong Q
    Oncogene; 2018 May; 37(20):2728-2745. PubMed ID: 29511351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
    Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
    Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
    Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional evidence of HS5-1 enhancer eRNA PEARL for protocadherin alpha gene regulation.
    Xu SY; Shou J; Wu Q
    Yi Chuan; 2022 Aug; 44(8):695-764. PubMed ID: 36384668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding Transcripts from Enhancers: New Insights into Enhancer Activity and Gene Expression Regulation.
    Chen H; Du G; Song X; Li L
    Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):201-207. PubMed ID: 28599852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer RNAs in transcriptional regulation: recent insights.
    Chen Q; Zeng Y; Kang J; Hu M; Li N; Sun K; Zhao Y
    Front Cell Dev Biol; 2023; 11():1205540. PubMed ID: 37266452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic functional characterization of antisense eRNA of protocadherin
    Zhou Y; Xu S; Zhang M; Wu Q
    Genes Dev; 2021 Oct; 35(19-20):1383-1394. PubMed ID: 34531317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancer transcribed RNAs arise from hypomethylated, Tet-occupied genomic regions.
    Pulakanti K; Pinello L; Stelloh C; Blinka S; Allred J; Milanovich S; Kiblawi S; Peterson J; Wang A; Yuan GC; Rao S
    Epigenetics; 2013 Dec; 8(12):1303-20. PubMed ID: 24135681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional enhancers: Transcription, function and flexibility.
    Melamed P; Yosefzon Y; Rudnizky S; Pnueli L
    Transcription; 2016; 7(1):26-31. PubMed ID: 26934309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
    Ko JY; Oh S; Yoo KH
    Mol Cells; 2017 Mar; 40(3):169-177. PubMed ID: 28359147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for additive and synergistic action of mammalian enhancers during cell fate determination.
    Choi J; Lysakovskaia K; Stik G; Demel C; Söding J; Tian TV; Graf T; Cramer P
    Elife; 2021 Mar; 10():. PubMed ID: 33770473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture.
    Kristjánsdóttir K; Dziubek A; Kang HM; Kwak H
    Nat Commun; 2020 Nov; 11(1):5963. PubMed ID: 33235186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional control by enhancers and enhancer RNAs.
    Lewis MW; Li S; Franco HL
    Transcription; 2019; 10(4-5):171-186. PubMed ID: 31791217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting enhancer transcription and activity from chromatin modifications.
    Zhu Y; Sun L; Chen Z; Whitaker JW; Wang T; Wang W
    Nucleic Acids Res; 2013 Dec; 41(22):10032-43. PubMed ID: 24038352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.